Friday, February 06, 2026 | 07:01 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Share Price

Know More
BSENSE

₹170.70-2.75 (-1.59%)

04:01 PM, 5-Feb-2026

₹170.07-4.30 (-2.47%)

03:44 PM, 5-Feb-2026

BSE : 507789

NSE : JAGSNPHARM

Sector : Health care

ISIN Code : INE048B01035

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 05-Feb-2026 | 04:01 PM IST

Add to PortfolioAdd to Watchlist

Market Cap (₹ Cr)

1,142

Traded Value (₹ Cr)

0.01

Volume (Shares)

750

Face Value (₹)

2

52-Week High (₹)

301.80

52-Week High Date

28-Jul-2025

52-Week Low (₹)

154.90

52-Week Low Date

22-Jan-2026

All Time High (₹)

328.02

All Time High Date

29-Nov-2024

All Time Low (₹)

0.55

All Time Low Date

18-Oct-1991

Jagsonpal Pharmaceuticals Ltd

Promoted by Rajpal Singh Kochhar in August 1978 Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously it has geared ...
Read More

Market News

More

Jagsonpal Pharma Announcement

Earnings Call Transcript for meeting held on 22 January 2026

In continuation to our earlier intimation dated January 15 2026 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the Jagsonpal Pharmaceuticals Limited Q3 FY26 Earnings Conference Call held on January 22 2026 at 5:00 P.M. for discussion of Q3 FY26 Financial Results is available on the Companys website at below link: https://www.jagsonpal.com/investor-relations/earning-calls.We request you to take the above on record.

Pursuant to Regulation 47 of SEBI (LODR) 2015 please find enclosed copies of advertisement published on January 22 2026 in Business Standard (English) and Business Standard (Hindi) newspaper providing extracts of Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025

Press release and investor presentation for the quarter and nine months ended December 31 2025

Press release and investor presentation for the quarter and nine months ended December 31 2025

More

Jagsonpal Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1,138

EPS - TTM (₹) [S]

6.11

P/E Ratio (X) [S]

27.83

Face Value (₹) 2
Latest Dividend (%)125.00
Latest Dividend Date 12-Sep-2025
Dividend Yield (%) 1.45
Book Value Share (₹) [S]37.81
P/B Ratio (₹) [S]4.50

[*C] Consolidated [*S] Standalone

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Motilal Oswal BSE Healthcare ETF 0.01 545 0.03
Bandhan BSE Healthcare Index Fund - Regular (G) 0.00 237 0.03
Bandhan BSE Healthcare Index Fund - Direct (G) 0.00 237 0.03

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

168.00

174.98

Week Low/High (₹)

159.15

185.00

Month Low/High (₹)

155.00

194.00

Year Low/High (₹)

155.00

302.00

All time Low/High (₹)

0.55

328.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week5.54%-90.16%0.91%0.88%
1 Month-10.54%-91.66%-2.49%-2.31%
3 Month-21.66%-92.68%-0.17%0.18%
6 Month-38.92%-94.31%3.23%4.03%
1 Year-32.16%-93.68%6.44%8.21%
3 Year29.00%-88.02%36.94%43.62%

Company Info

Company Information

Executive Director & MD : Manish Gupta

Chairperson : Harsha Raghavan

Independent Non Exe. Director : Pallavi Dinodia

Independent Non Exe. Director : Debasis Bikash Nandy

Non Executive Director : Prithipal Singh Kochhar

Company Sec. & Compli. Officer : Pratham Rawal

Independent Non Exe. Director : Radhika Dudhat

Chairman Emeritus : Rajpal Singh Kochhar

Registered Office: T-210 J, Shahpur Jat,New Delhi,New Delhi-110049 Ph: 91-011-46181100/46109900

Email:skmata@jagsonpal.com; cs@jagsonpal.com

URL:http://www.jagsonpal.com

FAQs about Jagsonpal Pharmaceuticals Ltd

1. What's the Jagsonpal Pharmaceuticals Ltd share price today?
Jagsonpal Pharmaceuticals Ltd share price was Rs 170.70 at 04:01 PM IST on 5th Feb 2026. Jagsonpal Pharmaceuticals Ltd share price was down by 1.59% from the previous closing price of Rs 173.45. Jagsonpal Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Jagsonpal Pharmaceuticals Ltd share price moved down by 10.54% on BSE.
  • Last 3 Months: Jagsonpal Pharmaceuticals Ltd share price moved down by 21.66% on BSE.
  • Last 12 Months: Jagsonpal Pharmaceuticals Ltd share price moved down by 32.16% on BSE.
  • Last 3 Years: Jagsonpal Pharmaceuticals Ltd share price moved up by 29.00% on BSE.


2. How can I quickly analyse the performance of the Jagsonpal Pharmaceuticals Ltd stock?
The performance of the Jagsonpal Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 27.83
  • Price to book value ratio is 4.50
  • Dividend yield of 1.45
  • The EPS (trailing 12 months) of the Jagsonpal Pharmaceuticals Ltd stock is Rs 6.11


3. What is the market cap of Jagsonpal Pharmaceuticals Ltd?
Jagsonpal Pharmaceuticals Ltd has a market capitalisation of Rs 1,142 crore.


4. What is Jagsonpal Pharmaceuticals Ltd's 52-week high/low share price?
The Jagsonpal Pharmaceuticals Ltd’s 52-week high share price is Rs 301.80 and 52-week low share price is Rs 154.90.


6. Which are Jagsonpal Pharmaceuticals Ltd’s peers in the Health care sector?
Jagsonpal Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Syncom Formul., Kwality Pharma, Bajaj Healthcare, Jagsonpal Pharma, Venus Remedies, Ind-Swift Labs., Fermenta Biotec..


7. Who owns how much in Jagsonpal Pharmaceuticals Ltd?
Key changes to the Jagsonpal Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Jagsonpal Pharmaceuticals Ltd has gone down to 67.39 per cent as of Dec 2025 from 67.78 per cent as of Mar 2025.